Dr. Kara Hoverson, MD

Dr. Hoverson practices at Clearway Surgery Center of Bethesda LLC in Bethesda, Maryland.

Dr. Hoverson's NPI, 1790197200, was assigned on June 2, 2014. Dr. Hoverson holds Maryland license D0094851.

Dr. Hoverson's primary practice is Clearway Surgery Center of Bethesda LLC, at 6410 Rockledge Dr, Bethesda, MD 20817 in Montgomery County. The practice phone is (855) 527-7246.

Dr. Hoverson's primary practice is Clearway Surgery Center of Bethesda LLC in Bethesda, Maryland. The medical group on file is Anne Arundel Dermatology. Dmand AI also links Dr. Hoverson to 3 more medical groups, 1 group practice or clinic and 1 ambulatory surgery center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hoverson practices, 2 sites in all. Vendor and product names are available with a free account.

Mohs-micrographic surgery is Dr. Hoverson's primary specialty in the NPI Registry, under taxonomy code 207ND0101X. Dmand AI has Dr. Hoverson's licenses on file in 2 states: Maryland and Virginia.

CMS data shows 1,113 Medicare services from Dr. Hoverson across 22 procedure codes in 2024, for 411 Medicare patients. Medicare paid $338,657 for them. Every service was in an office.

CMS counts 411 Medicare patients who saw Dr. Hoverson in 2024. The largest group is 75 to 84, with 187 patients. 75% of them have high cholesterol, and 72% have high blood pressure. Their average risk score is 1.04, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Hoverson's median patient age at 71, with 44% women.

In 2024, Dr. Hoverson wrote 50 Medicare Part D claims for 33 patients. 92% of them were for generic drugs. CMS names the drug for 11 of them, across 1 drug with 11 or more claims each, at $176 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 96 out of 100 for Dr. Hoverson for performance year 2024, reported as part of a group. Dr. Hoverson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 211 procedures of melanoma (skin cancer) excision by Dr. Hoverson, more than 97% of the clinicians it reports for that procedure.

Removal of nail tissue: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 13 papers to Dr. Hoverson, published from 2014 to 2020. 2015 was the busiest year, with 2. The most frequent topics are Biopsy, Diagnosis, Differential and Glucocorticoids. Dr. Hoverson has published most often in Cutis. Dr. Hoverson's most frequent co-authors are Kenneth Jay Helmandollar, MD, Wendi Elaine Wohltmann, MD and Leonard Charles Sperling, MD.

CMS Open Payments shows 26 general payments to Dr. Hoverson from 14 drug and device companies from 2019 to 2025. Food and beverage make up the largest share, 89% of the total. Merz North America, Inc. paid the most, $188.